$GSHD stock is up 13% today. Here's what we see in our data.

$GSHD stock has now risen 13% today, according to our price data from Polygon. There has been approximately $13,112,747 of trading volume.

Here is what we see in our data on $GSHD (you can track the company live on Quiver's $GSHD stock page):

$GSHD Insider Trading Activity

$GSHD insiders have traded $GSHD stock on the open market 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $GSHD stock by insiders over the last 6 months:

THOMAS MCCONNON has made 0 purchases and 2 sales selling 69,686 shares for an estimated $5,130,521.
MARK MILLER (President and CEO) purchased 5,000 shares for an estimated $361,700
LOUIS GOLDBERG purchased 5,575 shares for an estimated $250,038
JOHN TERRY O'CONNOR (General Counsel) purchased 2,100 shares for an estimated $150,801
MARK E. JR. JONES (CFO & COO) has made 2 purchases buying 873 shares for an estimated $64,986 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GSHD Hedge Fund Activity

We have seen 126 institutional investors add shares of $GSHD stock to their portfolio, and 140 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,177,933 shares (-81.5%) from their portfolio in Q4 2025, for an estimated $86,754,765
WASATCH ADVISORS LP added 559,087 shares (+32.3%) to their portfolio in Q1 2026, for an estimated $23,850,651
JACOBS LEVY EQUITY MANAGEMENT, INC removed 258,982 shares (-76.4%) from their portfolio in Q4 2025, for an estimated $19,074,024
AMERICAN CENTURY COMPANIES INC removed 227,936 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $16,787,486
PRICE T ROWE ASSOCIATES INC /MD/ removed 218,527 shares (-93.1%) from their portfolio in Q4 2025, for an estimated $16,094,513
FREESTONE GROVE PARTNERS LP added 188,271 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,866,159
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 143,181 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $10,545,280

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

EARLY ACCESS

Receive GSHD Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$GSHD Revenue

$GSHD had revenues of $93.1M in Q1 2026. This is an increase of 23.45% from the same period in the prior year.

You can track GSHD financials on Quiver Quantitative's GSHD stock page.

$GSHD Analyst Ratings

Wall Street analysts have issued reports on $GSHD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Keefe, Bruyette & Woods issued a "Outperform" rating on 02/18/2026
Piper Sandler issued a "Overweight" rating on 02/18/2026
Cantor Fitzgerald issued a "Overweight" rating on 01/14/2026
Jefferies issued a "Buy" rating on 12/01/2025
UBS issued a "Buy" rating on 10/27/2025

To track analyst ratings and price targets for $GSHD, check out Quiver Quantitative's $GSHD forecast page.

$GSHD Price Targets

Multiple analysts have issued price targets for $GSHD recently. We have seen 11 analysts offer price targets for $GSHD in the last 6 months, with a median target of $69.0.

Here are some recent targets:

Joshua Shanker from B of A Securities set a target price of $37.0 on 04/14/2026
Matthew Carletti from Citizens set a target price of $100.0 on 04/13/2026
Ryan Tunis from Cantor Fitzgerald set a target price of $67.0 on 04/09/2026
Pablo Singzon from JP Morgan set a target price of $58.0 on 04/09/2026
Brian Meredith from UBS set a target price of $81.0 on 04/08/2026
Tommy McJoynt from Keefe, Bruyette & Woods set a target price of $75.0 on 04/07/2026
Mark Hughes from Truist Securities set a target price of $58.0 on 02/18/2026

You can track data on $GSHD on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.